Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review

Published:2021-07-02 Issue:1 Volume:22 Page:37-44
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Rashki Kemmak Asma¹,Dolatshahi Zeinab²,Mezginejad Fateme³,Nargesi Shahin⁴

Affiliation:

1. Health Promotion Research Center, Zahedan University of Medical Science, Zahedan, Iran

2. Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran

3. Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

4. Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran

Funder

University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1941881

Reference26 articles.

1. Chronic Heart Failure: Contemporary Diagnosis and Management

2. Global Public Health Burden of Heart Failure

3. Long-term survival of cancer patients compared to heart failure and stroke: A systematic review

4. Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness analysis of endovascular versus open repair in patients with abdominal aortic aneurysm in Iran: A Cross-Sectional study;International Journal of Surgery;2024-03-19

2. Economic evaluation of vaccination against COVID‐19: A systematic review;Health Science Reports;2024-02

3. Xinshubao tablet ameliorates myocardial injury against heart failure via the DCN/PPARα/PGC-1α/P300 pathway;Biomedicine & Pharmacotherapy;2023-10

4. Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review;Cost Effectiveness and Resource Allocation;2022-12-01

5. Promising directions in the treatment of chronic heart failure: improving old or developing new ones?;Bulletin of Siberian Medicine;2022-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3